跳至主要内容
临床试验/NCT00162396
NCT00162396Unknown不适用

Evaluation of Genetic Factors That May Account for Variability in the Response to Salbutamol Among Patients Suffering From Asthma

Hadassah Medical Organization2 个研究点 分布在 1 个国家目标入组 150 人开始时间: 1999年8月最近更新:
适应症
相关药物

试验速览

阶段
不适用
入组人数
150
试验地点
2
主要终点
Change in lung function tests after salbutamol inhalation

研究概览

简要总结

The response to salbutamol varies greatly among individuals. Data from previous studies indicate that some of the variability is accounted for by genetic polymorphisms in the gene encoding for the adrenoceptor subtype β2. The current study was designed to evaluate variability in the response to salbutamol among recently diagnosed patients who have not been treated by β2 agonists or corticosteroids.

Lung function tests will be performed prior to and following a single dose administration of salbutamol through inhalation. Additional pharmacodynamic indices will be monitored including pulse and blood pressure. Three samples of plasma will be drawn for the evaluation of salbutamol plasma concentration.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Single Group
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 18 years and older
  • Recently diagnosed as asthmatic

排除标准

  • Current treatment by β2 agonist
  • Current treatment by corticosteroids
  • Acute asthma attack

结局指标

主要结局

Change in lung function tests after salbutamol inhalation

Change in blood pressure and pulse after salbutamol inhalation

次要结局

未报告次要终点

研究者

申办方类型
Other

研究点 (2)

Loading locations...

相似试验